尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Mylet Johanna, 首席财务官. Insider active across 1 company, notably Poseida Therapeutics, Inc.. Aggregated, 5 reports have been recorded. History available since 21 December 2021. The latest transaction was disclosed on 1 March 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Johanna Mylet is the Chief Financial Officer at Poseida Therapeutics, Inc. She is responsible for the financial management of the company, including financial planning and risk management. Her expertise in finance is essential to ensure the stability and growth of the organization.